Shilpa Medicare informs about updates

17 Nov 2025 Evaluate
Shilpa Medicare has informed about the launch of NODUCATM for the first time in India to treat metabolic dysfunction associated fatty liver disease (MAFLD).

The above information is a part of company’s filings submitted to BSE.

Shilpa Medicare Share Price

342.40 3.45 (1.02%)
11-Mar-2026 11:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1832.00
Dr. Reddys Lab 1328.60
Cipla 1332.80
Zydus Lifesciences 928.30
Lupin 2355.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×